BSETrident Texofab LtdMediumNeutral
Announced Thu, 25 Sept · 19:27 IST

Proceeding and Outcome of 17th Annual General Meeting (AGM) of the members of the Company.

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Trident Texofab held its 17th AGM on Thursday, September 25, 2025 via Video Conferencing, running from 4:00 p.m. to 4:18 p.m. (about 18 minutes). All key board members were present, including Chairman & Managing Director Hardik J Desai, Executive Director Manish Halwawala, three Independent Directors, the CFO, and the Company Secretary, along with the Statutory Auditor and Secretarial Auditor/Scrutinizer. Five ordinary business items were taken up: adoption of the audited financial statements for FY ending March 31, 2025, re-appointment of Director Manish Halwawala (retiring by rotation), appointment of Secretarial Auditors for five years, approval of related party transactions for FY 2025-26, and ratification of the Cost Auditor's remuneration for FY 2025-26. The Statutory Audit Report had no qualifications or adverse remarks, while the Secretarial Audit Report carried a qualification that the Board has already addressed with its reply. Remote e-voting ran from September 22 to September 24, 2025, and one registered speaker shareholder spoke in support of all agenda items. Consolidated e-voting results and the Scrutinizer's Report are to be filed with the stock exchanges within two working days.

Likely market impact

This is a routine procedural disclosure confirming the AGM was held; the actual pass/fail status and vote counts for each resolution (including the related-party transaction approval for FY26 and director re-appointment) are awaited and will be filed separately, so there is no immediate price-moving impact from this filing alone.